Yidu Tech (2158) H2 2025 earnings summary

Executive summary

• FY2025 revenue fell 11.4% YoY to RMB715.0m, while the loss narrowed 38.9% to RMB135.2m, the lowest for the period historically; operating cash outflow improved 23.8%.

• A focus strategy centers on YiduCore and its data-algorithm-scenario flywheel, with AI solutions spanning hospitals, life sciences and health management.

Financial highlights

• Revenue was RMB715.0m versus RMB807.1m; gross profit fell 29.5% to RMB239.2m and operating loss narrowed 39.0% to RMB134.1m.

• Net loss narrowed to RMB135.2m from RMB221.2m; basic and diluted loss per share improved to RMB0.11 from RMB0.19.

• Net cash used in operating activities was RMB248.8m versus RMB326.4m; net cash and liquid investments totaled RMB3,309.1m at 31 March 2025.

Outlook and guidance

• Priorities include further YiduCore LLM and computing optimization, disease-focused research, AI-enabled customer experience and efficiency, and ecosystem development through partnerships, investments and acquisitions.

• BDPS plans to expand hospital and regional networks and progress customers from point tools to full-chain AI; LSS will advance its i-Series, real-world evidence and high-quality client base.

• HMPS priorities are growing active users, exploring AI-enabled care models and improving user experience; no numerical FY2026 guidance was stated.